Roche Company Profile

« Back to Dashboard

What is the competitive landscape for ROCHE

ROCHE has sixty-one approved drugs.

Summary for Roche

US Patents:	0
Tradenames:	49
Ingredients:	45
NDAs:	61

Drugs and US Patents for Roche

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche	AZO GANTRISIN	phenazopyridine hydrochloride; sulfisoxazole	TABLET;ORAL	019358-001	Aug 31, 1990		DISCN	Yes	No
Roche	AZO GANTANOL	phenazopyridine hydrochloride; sulfamethoxazole	TABLET;ORAL	013294-001	Sep 10, 1987		DISCN	Yes	No
Roche Palo	TORADOL	ketorolac tromethamine	TABLET;ORAL	019645-001	Dec 20, 1991		DISCN	Yes	No
Roche Palo	TICLID	ticlopidine hydrochloride	TABLET;ORAL	019979-002	Oct 31, 1991		DISCN	No	No

Expired US Patents for Roche

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	KYTRIL	granisetron hydrochloride	INJECTABLE;INJECTION	020239-004	Mar 11, 1994	4,886,808
Roche Palo	CELLCEPT	mycophenolate mofetil hydrochloride	INJECTABLE;INJECTION	050758-001	Aug 12, 1998	5,543,408
Roche Palo	CELLCEPT	mycophenolate mofetil	CAPSULE;ORAL	050722-001	May 3, 1995	4,753,935
Roche	KLONOPIN RAPIDLY DISINTEGRATING	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	020813-002	Dec 23, 1997	4,305,502

Paragraph IV (Patent) Challenges for ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	30 mg and 45 mg		2011-08-02
	Injection	0.1 mg/mL, 1 mL single dose vial		2007-03-08
	Injection	1 mg/mL, 4 mL multi-dose vials		2004-07-19
	Tablets	2.5 mg and 150 mg		2007-05-16
	Capsule	75 mg		2010-11-15
	Oral Suspension	6 mg/mL		2015-06-18
	Injection	1 mg/mL, 1 mL vials		2004-06-01
	Injection	1 mg/mL, 3 mL Vial		2007-08-31
	For Oral Suspension	200 mg/mL		2011-03-25

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Roche
• Roche Palo